LarryJCopelandMD

PubMed

• A Plain Language Summary of "Dostarlimab for primary advanced or recurrent endometrial cancer".
  Mansoor R Mirza, Dana M Chase, Brian M Slomovitz, René dePont Christensen, Zoltán Novák
  Future Oncology. 2024-07-11
• Predictors of long-term progression-free survival in patients with ovarian cancer treated with niraparib in the PRIMA/ENGOT-OV26/GOG-3012 study.
  Whitney S Graybill, Beatriz Pardo Búrdalo, David M O'Malley, Ignace Vergote, Bradley J Monk
  International Journal of Gynecological Cancer. 2024-07-01
• RETRACTED: Cost-effectiveness of chemotherapy and dostarlimab for advanced or recurrent endometrial cancer.
  Courtney J Riedinger, David A Barrington, Christa I Nagel, Wafa K Khadraoui, Paulina J Haight
  Gynecologic Oncology. 2024-04-01

Journal Articles

• Radiation-associated Angiosarcoma Mimicking Fallopian Tube High-grade Serous Carcinoma in a Woman With De Novo Li-Fraumeni Syndrome  
  Sarah M. Crafton, Leigha Senter-Jamieson, James L. Chen, Larry J. Copeland, M.D., and Adrian A. Suarez, Int J Gynecol Pathol, 1/1/2018
• Less radical surgery for early-stage cervical cancer: Can conization specimens help identify patients at low risk for parametrial involvement?  
  Smith B, McCann GA, Phillips G, Backes FJ, O'Malley DM, Cohn DE, Fowler JM, Copeland LJ, Salani R, Gynecol Oncol, 1/1/2017
• Genetic consultation embedded in a gynecologic oncology clinic improves compliance with guideline-based care  
  Senter, L, O�Malley DM, Backes FJ, Copeland LJ, Fowler JM, Salani R, Cohn, DE, Gynecol Oncol, 1/1/2017
• Epigenetic silencing of MLH1 in endometrial cancers is associated with larger tumor volume, increased rate of lymph node positivity and reduced recurrence-free survival  
  Cosgrove CM, Cohn DE, Hampel H, Frankel WL, Jones D, McElroy JP, Suarez AA, Zhao W, Chen W. Salani R, Copeland LJ, O�Malley DM, Fowler JM, Yilmaz A, Chassen AS, Pearlm..., Gynecol Oncol, 1/1/2017
• Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomized, controlled, open-label, phase 3 trial (Gynecologic Oncolog...  
  Tewari KS, Sill MW, Penson RT, Huang H, Ramondetta LM, Landrum LM, Oaknin A, Reid TJ, Leitao MM, Michael HE, DiSaia PJ, Copeland LJ, Creasman WT, Stehman FB, Brady MF,..., Lancet, 1/1/2017
• An evaluation of progression free survival and overall survival of ovarian cancer patients with clear cell carcinoma versus serous carcinoma treated with platinum ther...  
  Oliver KE, Brady WE, Birrer M, Gershenson DM, Fleming G, Copeland LF, Tewari K, Argenta PA, Mannel RS, Secord AA, Stephan JM, Mutch DG, Stehman FB, Muggia FM, Rose PG,..., Gynecol Oncol, 1/1/2017
• Documentation of Pregnancy Risk Assessment and Pregnancy Among Women Presenting for Gynecologic Oncology Consultation  
  Crafton S, Nekkanti S, Lynch C, Cohn DE, Fowler JM, Copeland LF, O�Malley DM, Salani R, Backes FJ, Eisenhauer EL, Int J Gynecol Cancer, 1/1/2016
• Survival outcomes of obese patients in type II endometrial cancer: defining the prognositic impact of increasing BMI  
  Billingsley C, Cansino C, O�Malley, DM, Cohn DE, Fowler, JM, Copeland, LJ, Backes FJ, Salani R, Gynecol Oncol, 1/1/2016
• Does time interval between surgery and intraperitoneal chemotherapy administration in advanced ovarian cancer carry a prognostic impact? An NRG Oncology/Gynecologic On...  
  Garcia-Soto AE, Java JJ, Nieves Neira W, Pearson JM, Cohn DE, Lele SB, Tewari KS, Walker JL, Alvarez Secord A, Armstrong DK, Copeland LJ, Gynecol Oncol, 1/1/2016
• Disease extent at secondary cytoreductive surgery is predictive of progression-free and overall survival in advanced stage ovarian cancer: An NRG Oncology/Gynecologic ...  
  Rose PG, Java JJ. Morgan MA, Alvarez-Secord A, Kesterson JP, Stehman FB, Warshal DP, Creasman WT, Hanjani P, Morris RT, Copeland LJ, Gynecol Oncol, 1/1/2016
• Candidate genetic modifers for breast and ovarian cancer risk in BRCA1 and BRCA2 mutation carriers  
  Peterlongo P, Chang-Claude J, Moysick KB � Copeland LJ � et al, Cancer Epidemiology, Biomarkers & Prev,, 1/1/2015
• The use of transvaginal ultrasound in type II endometrial cancer  
  Billingsley CC, Kenne KA, Cansino CD, Backes FJ, Cohn DE, O�Malley DM, Copeland LJ, Fowler JM, Salani R, Int J Gynecol Cancer, 1/1/2015
• Evaluation of the Hematologic Safety of Same Day Versus Standard Administration 924 to 72 hours delay) of Pegfligrastim in Gynecology Oncology Patients Undergoing Cyto...  
  Billingsley C, Jacobson SN, Crafton SM, Crim AK, Li Q, Hade EM, Cohn DE, Fowler JM, Copeland LJ, Salani R, Backes FJ, O�Malley DM, Int J Gynecol Cancer, 1/1/2015
• Setting the bar: compliance with ovarian cancer quality indicators at a National Cancer Institute-designated Comprehensive Cancer Center  
  Liang ML,. ElNaggar AC, Nekkanti S, O�Malley DM, Hade EM, Copeland LJ,. Fowler JM, Salani R, Backes FJ, Cohn DE, Gynecol Oncol, 1/1/2015
• Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel and bevacizumab for advanced ovarian cancer � a phase I study  
  Salani R, O�Malley DM, Copeland LJ, Cohn DE, Backes FJ, Fowler JM, Eisenhauer EL, Int J Gynecol Cancer, 1/1/2014
• A Phase II Study of Gemcitabine, Carboplatin and Bevacizumab for the Treatment of Platinum-Sensitive Recurrent Ovarian Cancer  
  Eisenhauer EL, Zanagnolo V, Cohn DE, Salani R, O�Malley DM, Sutton G, Gallahan MJ, Cobb B, Fowler JM, Copeland LJ, Gynecol Oncol, 1/1/2014
• Outpatient Rapid 4-Step Desensitization for Gynecologic Oncology Patients with Mild to Low Risk Moderate Hypersensitivity Reactions to Carboplatin/Cisplatin  
  Li Q, Cohn D, Waller A, Backes F, Copeland L, Fowler J, Salani R, O�Malley D, Gynecol Oncol, 1/1/2014
• Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?  
  Backes FJ, Billingsley CC, Martin DD, Tierney B, Eisenhauer EL, Cohn DE, O�Malley D, Salani R, Copeland L, Fowler J, Gynecol Oncol, 1/1/2014
• Neuroendocrine carcinoma of the uterine cervix: the role of multimodality therapy in early-stage disease  
  McCann GA, Boutsicaris CE, Preston MM, Backes FJ, Eisenhauer EL, Cohn DE, Fowler JM, Copeland LJ, Salani R, O�Malley DM, Gynecol Oncol, 1/1/2013
• Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?  
  Backes FJ, Richardson DL, McCann GA, Smith B, Salani R, Eisenhauer EL, Fowler JM, Copeland LJ, Cohn DE, O�Malley DM, Int J Gynecol Cancer, 1/1/2013
• Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group study  
  Landrum LM, Java J, Matthews CA, Lanneau GS Jr, Copeland LJ, Armstrong DK, Walker JL, Gynecol Oncol, 1/1/2013
• Effects of chemotherapy delays and dose reductions on progression free and overall survival in the treatment of epithelial ovarian cancer  
  Nagel CI, Backes FJ, Hade EM, Cohn DE, Eisenhauer EL, O�Malley DM, Fowler JM, Copeland LJ, Salani R, Gynecol Oncol, 1/1/2012
• The new American Journal of Obstetrics and Gynecology, 5 Years Later: Looking back and moving forward  
  Romero R, Garite TJ, Kim MH, Quilligan EJ, Bump RC, Carson SA, Copeland LJ, Grobman WA, Iams JD, Jenkins TR, Kilpatrick SJ, Macones GA, Parry S, Phipps MG, Am J Obstet Gynecol, 1/1/2012
• Point: Chemosensitivity assays have a role in the management of recurrent ovarian cancer  
  Schink JC, Copeland LJ, JNCCN, 1/1/2011
• PRO: Secondary surgical debulking is an acceptable option in patients with recurrent platinum-sensitive ovarian cancer  
  Nagel CI, Carlson MJ, Copeland LJ, Clin Ov Ca, 1/1/2011
• Join now to see all

Books/Book Chapters

• Clinical Gynecologic Oncology 
  Chapter: Epithelial ovarian cancer 
  Page 313 - 367Copeland LJEditors: DiSaia PJ, Creasman WT.Elsevier, Inc., Philadelphia, PAEdition 7th,2007
• Clinical Gynecology 
  Chapter: Gestational trophoblastic disease 
  Page 711 - 725Ben-Shachar I and Copeland LJEditors: Bieber EJ, Sanfilippo JS, Horiwitz IR.Churchill Livingstone Elsevier, Philadelphia, PA2006
• Conn�s Current Therapy 
  Chapter: Cancer of the uterine cervix 
  Page 1238 - 1241Copeland LJ and Selman AEditors: Rakel RE, Bope ET.W.B. Saunders Co., Philadelphia, PAEdition 57th,2005
• Peptides for the New Millennium 
  Chapter: Evaluation of the immunogenicity of peptide and DNA constructs for HER-2/neu epitopes 
  Jiang H, Walker C, Fowler J, Copeland L, Kaumaya PEditors: Fields GB and Barany G.Kluwer Academic Publishers, Dordrecht, Netherlands2005
• Gynecologic Cancer: Controversies in Management 
  Chapter: Vaginal reconstruction in pelvic exenteration 
  Cohn DE and Copeland LJEditors: Gershenson DM, McGuire WP, Gore M, Thomas G, Quinn M.Churchill Livingstone, Inc., London, EnglandEdition 1st,2004
• Conn�s Current Therapy 
  Chapter: Neoplasms of the vulva 
  Page 1133 - 1136Cohn DE and Copeland LJEditors: Rakel RE, Bope ET.W.B. Saunders Co., Philadelphia, PAEdition 56th,2004
• Textbook of Gynecology 
  Chapter: Uterine sarcomas 
  Page 1321 - 1332Nicklin JL, Copeland LJEditors: Copeland LJ.W.B. Saunders Co., Philadelphia, PAEdition 2nd,2000
• Textbook of Gynecology 
  Chapter: Clinical anatomy of the pelvis 
  Page 17 - 57Doherty MG, Copeland LJ, Powell MAEditors: Copeland LJ.W.B. Saunders Co., Philadelphia, PA2000
• Textbook of Gynecology 
  Chapter: Urinary tract injury and fistula 
  Page 1093 - 1103Copeland LJ, Hatch KD, Fowler JMEditors: Copeland LJ.W.B. Saunders Co., Philadelphia, PA2000
• Textbook of Gynecology 
  Chapter: Papillary serous carcinoma of the peritoneum 
  Page 1375 - 1387Selman AE, Niemann TH, Copeland LJEditors: Copeland LJ.W.B. Saunders Co., Philadelphia, PAEdition 2nd,2000
• Textbook of Gynecology 
  Chapter: Germ cell, stromal, and miscellaneous ovarian neoplasms 
  Page 1389 - 1402Copeland LJEditors: Copeland LJ.W.B. Saunders Co., Philadelphia, PA2000
• Operative Gynecology 
  Chapter: Reconstructive surgery in gynecologic oncology 
  Page 780 - 802Copeland LJEditors: Gershenson DM, DeCherney A, Curry S, Brubaker L.W.B. Saunders Co., Philadelphia, PA2000
• Textbook of Gynecology 
  Editors: LJ Copeland, Associate editor JF Jarrell.W.B. Saunders, Philadelphia, PA2000
• The Merck Manual 
  Chapter: Gynecologic neoplasms 
  Page 1960 - 1972Fowler JM, Copeland LJEdition 17th,1999
• Handbook of Obstetrics, Gynecology, and Primary Care 
  Chapter: Ovarian cancer 
  Page 124 - 133Nicklin JL, Copeland LJEditors: Zuspan FP, Quilligan EJ.Mosby-Year Book1998
• Handbook of Obstetrics, Gynecology, and Primary Care 
  Chapter: Gestational trophoblastic disease 
  Page 55 - 63Copeland LJ, Nicklin JLEditors: Zuspan FP, Quilligan EJ.Mosby-Year Book1998
• Textbook of Uncommon Cancer 
  Chapter: Extra-ovarian primary peritoneal carcinomas 
  Page 641 - 651Selman AE, Copeland LJEditors: Raghaven D, Brecher ML, Johnson DH, Meropol NJ, Moots PL, Thigpen JT.Wiley, Europe1998
• Essentials of Gynecologic Cancer 
  Chapter: Quality of life in gynecologic cancer 
  Page 317 - 335Andersen BL, Copeland LJEditors: Lawton F, Friedlander M, Thomas G.Chapman & Hall1998
• Ovarian Cancer: Controversies in Management 
  Chapter: Second-look surgery 
  Page 85 - 100Nicklin JL, Copeland LJEditors: Gershenson DM, McGuire WP.Churchill Livingstone, Inc.1998
• Obstetrics: Normal and Problem Pregnancies 
  Chapter: Malignant diseases and pregnancy 
  Page 1155 - 1182Copeland LJ, Landon MBEditors: Gabbe SG, Niebyl JR, Simpson JL.Churchill Livingstone, Inc., New York, NYEdition 3rd,1997
• Advances in Obstetrics and Gynecology 
  Chapter: Second-look laparotomy and secondary tumor reduction in epithelial ovarian cancer 
  Page 439 - 454Nicklin JL, Copeland LJEditors: Rock J, Horwitz I.Mosby, Chicago, IL1996
• Expert Consultations in Gynecological Cancers 
  Chapter: Ovarian cancer, epithelial (early disease, unstaged) 
  Page 484 - 485Copeland LJ, Nicklin JLEditors: Markman M, Belinson, J.Marcel Dekker, New York, NY1996
• Surgical Clinics of North America 
  Chapter: Surgical issues in the management of carcinoma of the cervix in pregnancy 
  Page 89 - 1000Lewandowski GS, Vaccarello L, Copeland LJEditors: Delgado G.W.B. Saunders, Philadelphia, PA1995
• Study Guide for Textbook of Gynecology 
  Editors: LJ Copeland, Associate editors JF Jarrell, JA McGregor.W.B. Saunders, Philadelphia, PA1994
• Obstetrics and Gynecology Clinics of North America 
  Chapter: Second-look laparotomy in epithelial ovarian cancer 
  Copeland LJ, Vaccarello L, Lewandowski GSEditors: Gershenson DM.W.B. Saunders, Philadelphia, PA1994
• Join now to see all

Abstracts/Posters

• Outpatient rapid desensitization for gynecologic oncology patients with moderate to severe hypersensitivity reactions to platinums
  A Li, DE Cohn, AG Rhoades FJBackes LJ Copeland JM Fowler R. Salani, DM O�Malley, Proc Soc Gynecol Oncol, 1/1/2015
• Outcomes in state III Endometrial cancer are similar for chemotherapy +/- radiation in low and high risk histology
  C Cosgrove, G. Argrawal, LJ Copeland, DM O�Malley, R Salani DE Cohn, JM Fowler, Proc Soc Gynecol Oncol, 1/1/2015
• The use of NCCN guideline therapy in the first line/adjuvant setting in patients with ovarian cancer from 6 NCCN institutions
  J. Niland, MA Bookman, RA Burger, M Cristea,J Griggs, GM Mantia-Smaldone, LA Meyer, CC L Lun, A Wright DE Cohn, Proc Soc Gynecol Oncol, 1/1/2015
• Setting the bar: compliance with ovarian cancer quality indicators at a national Cancer Institute (NCI) � designated Comprehensive Cancer Center (CCC)
  AC ElNaggar, S. Nekkanti, DM O�Malley, EM Hade, LJ Copeland, JM Fowler, R Salani FJ Backes, DE Cohn, Proc Soc Gynecol Oncol, 1/1/2015
• Adherence to a standard algorithm results in high negative predictive value of sentinel lymph node assessment using indocyanine green (ICG) and isosulfan blue (ISB) dy...
  DM O�Malley, R. Salani, DE Cohn, LJ Copeland, JM Fowler, Proc Soc Gynecol Oncol, 1/1/2015
• The futility of transvaginal ultrasound in type II endometrial cancer
  C. Billingsley, K. Kenne, C. Cansino, D. O�Malley, D. cohn. J. Fowler, E. Eisenhauer, L. Copeland, F. Backes, R. Salani, Proc Soc Gynecol Oncol, 1/1/2014
• Evaluation of the hematologic safety of same day versus 24-72 hour delayed administration of pegfilgrastim in gynecology oncology patients undergoing chemotherapy
  Billingsley, Caroline, Samuel Jacobson, Sarah Crafton, Aleia Crim, Quan Li, Erinn Hade, Davie E. Cohn, Fowler, Jeffrey, Larry Copeland, Ritu Salani, Floor Backes, Davi..., ASCO Annual Meeting, 1/1/2014
• Feasibility of interval cytoreduction following neoadjuvant chemotherapy with carboplatin, weekly paclitaxel, and bevacizumab for advanced ovarian cancer - A phase I S...
  R. Salani, D. O�Malley, L. Copeland, D. Cohn, J. Fowler, E. Eisenhauer, SGO Meeting, 1/1/2013
• A phase II evaluation of carboplatin/paclitaxel/bevacizumab in the treatment of advanced stage endometrial carcinoma
  D. O�Malley, G. McCann, J. Fowler, L. Copeland, F. Backes, R. Salani, E. Eisenhauer, D. Cohn, SGO Meeting, 1/1/2013
• Prospective evaluation of postoperative pain and quality of recovery in patients undergoing robotic vs. laparotomy for staging of endometrial cancer
  D. Tulman, L. Huffman, S. Bergese, J. Fowler, D. O�malley, R. Salani, E. Eisenhauer, L. Copeland, D. Cohn, SGO Meeting, 1/1/2013
• Preoperative tumor grade and intraoperative tumor size identifies patients at intermediate risk for lymph node involvement but not necessarily those at increased risk ...
  K. Rath, G. McCann, A. Clements, F. Backes, R. Salani, J. Fowler, E. Eisenhauer, D. Cohn, L. Copeland, D. O�Malley, SGO Meeting, 1/1/2013
• Are postmenopausal women with body mass indices <30 with grade 1 endometrial cancer more likely than their obese counterparts to have advanced or recurrent disease?
  A. Clements, F. Backes, K. Rath, G. McCann, D. Cohn, J. Fowler, L. Copeland, R. Salani, E. Eisenhauer, D. O�Malley, SGO Meeting, 1/1/2013
• Does comprehensive staging made a difference for recurrence and survival of patients with high-intermediate risk endometrial cancer?
  F. Backes, L. Huffman, R. Farrell, L. Copeland, R. Salani, E. Eisenhauer, D. O�Malley, D. Cohn, J. Fowler, SGO Meeting, 1/1/2013
• A phase I study of intraperitoneal carboplatin with intravenous paclitaxel and bevacizumab in patients with previously untreated epithelial ovarian carcinoma or primar...
  D. O�Malley, E. Eisenhauer, G. McCann, R. Salani, F. Backes, L. Copeland, J. Fowler, D. Cohn, SGO Meeting, 1/1/2013
• Prognostic factors for stage III epithelial ovarian cancer treated with intraperitoneal chemotherapy: A Gynecologic Oncology Group Study
  Landrum L, Java J, Mathews CA, Lanneau GS JR, Copeland L, Armstrong D, Walker J, SGO Meeting, 1/1/2012
• Can cold knife cone pathologic specimens safely predict parametrial involvement?
  McCann G, Taege S, Boutsicaris C, Casino C, Eisenhauer E, Fowler J, Cohn D, Copeland L, O�Malley D, Salani R, SGO Meeting, 1/1/2012
• When are surgical margins after radical hysterectomy too close?
  McCann G, Taege S, Boutsicaris C, Cansino C, Eisenhauer E, Fowler J, Cohn D, Copeland L, O�Malley D, Salani R, SGO Meeting, 1/1/2012
• Should bevacizumab be continued after progression on bevacizumab in recurrent ovarian cancer?
  Backes F, Richardson D, McCann G, Salani R, Eisenhauer E, Fowler J, Copeland L, Cohn D, O�Malley D, SGO Meeting, 1/1/2012
• Retreatment with bevacizumab after an initial complete response to a bevacizumab-containing regimen, BCR significantly improves PFS in patients with EOC
  McCann G, Smigh B, Backes F, Rath R, Salani R, Eisenhauer E, Fowler J, Copeland L, Cohn D, SGO Meeting, 1/1/2012
• A phase II study of gemcitabine, carboplatin and bevacizumab for the treatment of platinum-sensitive recurrent ovarian cancer
  Eisenhauer EL, Zanagnolo V, Cohn DE, Salani RS, O�Malley DM, Sutton G, Callahan M, Cobb R, Vaughan M, Fowler J, Copeland L, Proc Soc Gynecol Oncol, 1/1/2011
• A phase II evaluation of carboplatin/paclitaxel/bevacizumab in the treatment of advanced stage endometrial carcinoma � Report of toxicity
  O�Malley D, Phillips G, Eisenhauer E, Salani R, Copeland L, Fowler J, Cohn DE, Proc Soc Gynecol Oncol, 1/1/2011
• Effect of chemotherapy delays and dose reductions on progression-free survival in the treatment of epithelial ovarian cancer
  Nagel C, Backes F, Donner J, Hade E, Copeland L, Fowler J, Cohn D, O�Malley D, Eisenhauer E, Salani R, Proc Soc Gyncol Oncol; Gyncol Oncol, 1/1/2010
• Addition of bevacizumab to weekly paclitaxel significantly improves progression-free survival in heavily pretreated recurrent epithelial ovarian cancer
  Hurt J, Backes F, Rheaume S, Richardson D, Fowler J, Copeland L, Cohn D, Eisenhauer E, Salani R, O�Malley D, Proc Soc Gyncol Oncol; Gyncol Oncol, 1/1/2010
• Clinical and pathologic correlation of the tumor suppressor PAR4 in surgically staged endometrial cancer
  Resnick KE, Ivanov I, Carlson MJ, O�Malley DM, Fowler JM, Copeland LJ, Cohn DE, Proc Soc Gynecol Oncol, 1/1/2009
• Does repeat usage of bevacizumab in patients with progressive recurrent ovarian cancer offer a survival advantage?
  Richardson DL, Backes FJ, Seamon LG, Hurt JD, Cohn DE, Fowler JM, Copeland LJ, O�Malley DM, Proc ASCO, 1/1/2009
• Join now to see all

Other

• Sarah Crafton, Leiga Senter, James Chen, Larry Copeland, Adrian Suarez 
  Sarah Crafton, Leiga Senter, James Chen, Larry Copeland, Adrian Suarez
  1/1/2018
• Oncology: Treatment and Management, 6th Edition (Course Consultant: Copeland LJ, Saul PB) 
  CMR Institute, Inc.
  1/1/2014
• Severe Pegfilgrastim-Induced Bone Pain completely Alleviated with Loratadine: A Case Report 
  Romeo C, Copeland L, Li Q
  1/1/2014
• Commentary for �Gynecologic malignancies in older women� by Mirhashemi R, Nieves-Neira W, and Averette HE 
  Billingsley CC, Copeland LJ, OB GYN News
  1/1/2014
• Oncology: Treatment and Management, 5th Edition (Course Consultant: Copeland LJ, Pace MB, Saul PB) 
  CMR Institute, Inc.
  1/1/2010
• �Importance and Role of Clinical Trials� in State of the State Gynecologic Cancers: Fourth Annual Report to the Women of America 
  Gynecologic Cancer Foundation
  1/1/2006
• Combining GEMZAR with platinum to treat relapsed ovarian cancer: an approach to addressing platinum resistance (Consulting Editor: Copeland LJ) 
  Nagourney RA, et al, Lilly Monograph
  1/1/2003
• Teaching in the Operating Room - Clinical Teaching Handbook 
  Copeland LJ, Ohio State University College of Medicine and Public Health
  1/1/2001
• Screening for familial ovarian cancer 
  Nicklin JL, Copeland LJ, Ohio Medical Education Network and Television (OMEN & OMEN TV)
  1/1/1995
• Abnormal vaginal bleeding and gynecologic cancer 
  Kington K, Copeland LJ, Ohio Medical Education Network (OMEN)
  1/25/1991
• PROLOG Surgery & Gynecologic Oncology - 2nd edition 
  American College of Obstetrics and Gynecology
  1/1/1990
• Cervical Cancer Syllabus - Core Curriculum Series for Primary Care Physicians 
  University of Texas M.D. Anderson Cancer Center and the American Cancer Society, Texas Division, In
  1/1/1990
• Gynecologic Oncology Student Syllabus 
  Department of Gynecology, UT M.D. Anderson Hospital and Tumor Institute
  1/1/1987
• Tele Lecture Clinics: Management of Ovarian Germ Cell Tumors 
  Obstetrics & Gynecology Forum (National Gynecology & Obstetrics Information Network)
  1/1/1987
• Sarcoma Botryoides 
  Practical Review Obstet & Gynecol (PROG) Educational Reviews, Inc.
  1/1/1985
• Second-look Laparotomy for Ovarian Carcinoma 
  Practical Review Obstet & Gynecol (PROG) Educational Reviews, Inc.
  1/1/1985
• Core Curriculum Cancer of Cervix: Cassette Program 6 follow-up and Recurrences 
  Southern Medical Association
  1/1/1983
• U.S. Department of Health and Human Services, International Cancer Research Data Bank Oncology Overview: Diagnosis and Treatment of Pediatric and Adolescent Gynecolog... 
  
  1/1/1983
• How best to proceed when the Pap smear is abnormal 
  Copeland LJ, Your Patient and Cancer
  1/1/1983
• Core Curriculum Cancer of Cervix: Video Cassette Program 5 Complications, Controversies, and Special Sitution 
  Southern Medical Association
  1/1/1983
• Core Curriculum Cancer of Cervix: Video Cassette Program 4 Treatment Modalities 
  Southern Medical Association
  1/1/1983
• Core Curriculum of Cervix: Video Cassette Program 3 Staging and Treatment Overview 
  Southern Medical Association
  1/1/1983
• Core Curriculum Cancer of Cervix: Video Cassette Program 2 Management of the Abnormal Pap Smear 
  Southern Medical Association
  1/1/1983
• Core Curriculum Cancer of Cervix: Video Cassette Program 1 Natural History and Detection 
  Southern Medical Association
  1/1/1983
• Dial Access Program Staging Carcinoma of Cervix 
  Southern Medical Association
  1/1/1983
• Join now to see all